SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-014418
Filing Date
2017-08-10
Accepted
2017-08-10 16:08:58
Documents
18
Period of Report
2017-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20170808_8k.htm 8-K 28206
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 155547
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 5253
4 slide13.jpg GRAPHIC 42645
5 slide12.jpg GRAPHIC 45538
6 slide11.jpg GRAPHIC 89231
7 slide10.jpg GRAPHIC 158423
8 slide9.jpg GRAPHIC 116762
9 slide8.jpg GRAPHIC 165665
10 slide7.jpg GRAPHIC 141814
11 slide6.jpg GRAPHIC 169048
12 slide5.jpg GRAPHIC 128475
13 slide4.jpg GRAPHIC 127947
14 slide3.jpg GRAPHIC 61147
15 slide2.jpg GRAPHIC 271954
16 slide1.jpg GRAPHIC 45538
17 ex99-1img002.jpg GRAPHIC 3740
18 ex99-1img001.jpg GRAPHIC 2054
  Complete submission text file 0001437749-17-014418.txt   2353963
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 171021547
SIC: 2834 Pharmaceutical Preparations